NDC 79622-012

Tembexa

Brincidofovir

Tembexa is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Chimerix, Inc.. The primary component is Brincidofovir.

• Product ID: 79622-012_2f140fb3-5828-484b-b006-529b7f31c036
• NDC: 79622-012
• Product Type: Human Prescription Drug
• Proprietary Name: Tembexa
• Generic Name: Brincidofovir
• Dosage Form: Suspension
• Route of Administration: ORAL
• Marketing Start Date: 2022-04-20
• Marketing Category: NDA /
• Application Number: NDA214460
• Labeler Name: Chimerix, Inc.
• Substance Name: BRINCIDOFOVIR
• Active Ingredient Strength: 10 mg/mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 79622-012-65

65 mL in 1 BOTTLE (79622-012-65)

• Marketing Start Date: 2022-04-20
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Tembexa" or generic name "Brincidofovir"

NDC	Brand Name	Generic Name
79622-010	Tembexa	Brincidofovir
79622-012	Tembexa	Brincidofovir